Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Return to Work and Participation in Society After Out-of-Hospital Cardiac Arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Syncope and Its Impact on Occupational Accidents and Employment: A Danish Nationwide Retrospective Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Knowledge about drug-drug interactions commonly arises from preclinical trials, from adverse drug reports, or based on knowledge of mechanisms of action. Our aim was to investigate whether drug-drug interactions were discoverable without prior hypotheses using data mining. We focused on warfarin-drug interactions as the prototype.

METHODS AND RESULTS: We analyzed altered prothrombin time (measured as international normalized ratio [INR]) after initiation of a novel prescription in previously INR-stable warfarin-treated patients with nonvalvular atrial fibrillation. Data sets were retrieved from clinical work. Random forest (a machine-learning method) was set up to predict altered INR levels after novel prescriptions. The most important drug groups from the analysis were further investigated using logistic regression in a new data set. Two hundred and twenty drug groups were analyzed in 61 190 novel prescriptions. We rediscovered 2 drug groups having known interactions (β-lactamase-resistant penicillins [dicloxacillin] and carboxamide derivatives) and 3 antithrombotic/anticoagulant agents (platelet aggregation inhibitors excluding heparin, direct thrombin inhibitors [dabigatran etexilate], and heparins) causing decreasing INR. Six drug groups with known interactions were rediscovered causing increasing INR (antiarrhythmics class III [amiodarone], other opioids [tramadol], glucocorticoids, triazole derivatives, and combinations of penicillins, including β-lactamase inhibitors) and two had a known interaction in a closely related drug group (oripavine derivatives [buprenorphine] and natural opium alkaloids). Antipropulsives had an unknown signal of increasing INR.

CONCLUSIONS: We were able to identify known warfarin-drug interactions without a prior hypothesis using clinical registries. Additionally, we discovered a few potentially novel interactions. This opens up for the use of data mining to discover unknown drug-drug interactions in cardiovascular medicine.

Original languageEnglish
JournalCirculation. Cardiovascular quality and outcomes
Issue number6
Pages (from-to)621-628
Publication statusPublished - Nov 2016

    Research areas

  • Administrative Claims, Healthcare, Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Blood Coagulation, Data Mining, Drug Interactions, Drug Prescriptions, Female, Humans, International Normalized Ratio, Logistic Models, Machine Learning, Male, Pilot Projects, Polypharmacy, Predictive Value of Tests, Registries, Retrospective Studies, Risk Factors, Warfarin, Journal Article

ID: 52410902